EB
EBOS Group Limited
EBOSY · OTC
$23.30 +0.00% (+$0.00)
1M -10.73%
Market Cap $1.68B
P/E Ratio 7.62x
Div. Yield 6.16%
ROE 8.23%
Bulios Fair Price
$28.28
21.4% upside
Current Price
$23.3
Undervalued Fair Value Overvalued
According to Bulios Fair Price, EBOSY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
94 /100
Cheap EV/EBITDA 6.11x
P/S 0.13x
P/B 0.61x
Growth
16 /100
Declining Rev. growth 2.51%
FCF growth 12.61%
Book val. growth 4.10%
Profitability
12 /100
Weak Net margin 1.67%
Op. margin 2.80%
FCF margin 1.61%
Quality
42 /100
Average ROE 8.23%
ROA 2.82%
Asset turnover 1.69x
Debt
50 /100
Moderate Current ratio 1.16x
Int. coverage 3.03x
Net debt/EBITDA 3.03x
Stability
74 /100
Stable Rev. volatility 8.66%
EPS volatility 15.10%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EBOSY
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Adam Luke Hall
Employees
5,700
Headquarters
Docklands